originally isolated from culture medium of porcine aortic endothelial cells as a potent vasoconstrictor peptide.Subsequently,ET was also reported to be produced by nonvascular tissues and to be involved in various biological phenomena in these tissues.Recently,a high concentration of ET-1-like immunoreactivity(ET-1-LI)was found in human amniotic fluid.Amnion tissue also contained a large amount of ET-1-LI,and cultured amnion cells secreted large amounts of ET-1-LI.The major component of ET-1-LI in these samples was ET-1.Moreover,the expression of prepro-ET-1 mRNA was detected in both amnion tissue and cultured amnion cells,indicating that ET-1 in the amniotic fluid originated from amnion cells.In cultured amnion cells,ET-1 secretion was stimulated by EGF,TGF-f3,IL-1a,13 and TNF-a.In addition,specific receptors for ET,ET-AR and ET-BR were detected in myometrium,decidua vera,chorion laeve,and placenta at term by both ligand binding and Northern blot analysis.These findings suggest that ET-1 secreted from amnion cells plays a physiological role in human pregnancy.In this paper,the regulation of production of ET-1 and expression of receptors for ET-1 by avascular human amnion tissue are reviewed.The possible importance of amniotic ET in human pregnancy is also discussed.
peptides originally isolated from the culture medium of porcine aortic endothelial cells [1] .Three distinct ET-related genes are found in the human genomic library,and the corresponding peptides are designated as ET-1,ET-2 and ET-3 [2] .Prepro-ET-1 mRNA is constitutively expressed by cultured endothelial cells.ET-1 is also secreted from various non-vascular tissues including reproductive organs such as mammary tissue [3] ,decidual stromal cells of the maternal basal plate of the placenta [4] ,placental syncytiotrophoblasts and extravillous cytotrophoblasts [5] and amnion tissue [6] [7] [8] [9] .ET-2 and ET-3 are expressed in other tissues,such as the brain,kidney,adrenal,intestine and placenta [10] [11] [12] .
ET exerts biological activity through specific receptors.Two distinct cDNAs for ET receptors were identified.One of these,which is ET-1 selective,is expressed in vascular smooth muscle cells(ET-A receptor;ET-AR) [13] ,and the other,which is nonisopeptide-selective,is expressed in vascular endothelial cells(ET-B receptor;ET-BR) [14] .The order of affinity for ET-AR is ET-1>ET-2•âET-3, with the affinity of ET-1 or ET-2 being approximately two orders of magnitude higher than that of ET-3 [13, 15] .ET-BR has equipotent affinity for all three isopeptides [16] .Thus,ET-1 and ET-2 have high affinity for both ET-AR and ET-BR,but ET-3 Concentrations and molecular forms of ET-1-like immunoreactivity in human amniotic fluid A number of investigators [6] [7] [8] 28 , 29] report ET-1-like immunoreactivity (ET-1-LI) in the human amniotic fluid at a concentration several times higher than that found in maternal or fetal plasma [28, [30] [31] [32] . Figure 1 compares ET-1-LI levels in the amniotic fluid at various gestational ages with those in neonatal first urine, maternal plasma and umbilical venous plasma. ET-1-LI in amniotic fluid increases as gestation advances. Human amniotic fluid in the midtrimester contains big ET-1 and a larger form (6 kDa) of ET-1-LI [8, 28] . The concentration of this larger form of ET decreases towards term, and the mature form of ET-1 becomes the major constituent of ET-1-LI in the amniotic fluid at term [8] . ET-1-LI is also found in the first neonatal urine; however, its concentration is much lower than that in the amniotic fluid at term [8, 28] Relation between the amniotic fluid ET-1 concentration and labor
Because ET-1 can contract uterine smooth muscle by increasing intracellular calcium ion levels [34] , it was postulated that amniotic ET-1 may play a role in the initiation of labor [7] . However, reported changes in ET-1-LI concentration after the onset of labor are still controversial.
Some investigators found that the ET-1-LI level in the amniotic fluid of women with active labor was higher than that recorded before the onset of labor [7] . On the other hand, others reported that the ET-1-LI level in the amniotic fluid obtained after the onset of labor was similar to that found at the time of elective cesarean section before the onset of labor [8, 28] . Recently, Casey et al. [35] reported an additional finding that may help explain some of these contradictions; they found that the amniotic fluid concentration of ET-1-LI was higher below the fetal head than in the upper compartment of the amniotic cavity. Additionally, they found that the ET-1-LI concentration in the upper compartment did not change after the onset of labor. On the other hand, ET-1-LI secretion by cultured amnion cells was stimulated by cytokines [7, 9] . From these observations, they suggested that the increased ET-1-LI concentration in the forewaters was derived from amniotic tissue of the lower uterine segment stimulated by cytokines secreted from macrophages and/or leukocytes in the cervix and vagina [351.
Production of ET-1 by Avascular Human
Amniotic Tissue
Secretion of ET-1 by cultured human amnion cells
A variety of non-vascular cells including cultured human amnion cells were reported to secrete ET-1-LI [6, 8, 9] . ET-1-LI levels in human amnion tissue, obtained at the time of elective cesarean section at Fig. 2 , cultured human amnion cells produced and secreted large amounts of ET-1-LI in a time-dependent manner, and the major constituent of ET-1-LI in the culture media was ET-1 [8] . However, cells derived from chorion laeve or decidua vera tissue did not secrete ET-1-LI [8, 9] . The expression of prepro-ET-1 mRNA was detected in amniotic tissue and cultured amnion cells but not in decidua tissue [6, 7] . Thus, the findings on the ET-1 concentration and prepro ET-1 mRNA expression in the amniotic tissue were compatible with those in cultured amnion cells, indicating that ET-1 in human amniotic fluid originates mainly from amnion cells.
Regulation of ET-1 secretion from cultured amnion cells
ET-1 secretion from cultured human amnion cells was stimulated by cytokines such as IL-1/3, IL-6 and tumor necrosis factor-a (TNF-a) [7, 9] and by growth factors such as epidermal growth factor (EGF) and TGF-/3 [36] . Fig. 3 summarizes the effects of various substances on ET-1 secretion from cultured human amnion cells. Bacterial lipopolysaccharides (LPS) also stimulated ET-1 secretion from cultured human amnion cells [7] . The expression of prepro-ET-1 mRNA in cultured amnion cells was also stimulated by these substances [7] . Among these substances, EGF is physiologically present in amniotic fluid, and its concentra- . These results suggest that 70-80 % of the binding sites in these tissues are ET-BR. In contrast, neither ET-1 nor ET-3 binds to the membrane preparation of amnion tissue at term, indicating that amnion cells at term do not express ET receptors. In the membrane preparations of these tissues obtained after the onset of labor, a similar pattern of ET binding was observed. Northern blot analyses revealed that the patterns of expression of ET-AR and ET-BR mRNAs in these tissues were consistent with the results of the binding studies (Fig. 6 ).
ET receptors in intrauterine tissues in the second trimester
Binding analysis of ET receptors in the chorion 
Possible Roles of Amniotic ET in Human Pregnancy
ET actions on reproductive organs ET was reported to be involved in various reproductive phenomena such as contraction of myometrium [34] , contraction of feto-placental vessels [41, 42] , proliferation of placental fibroblasts [43] , PG production in cultured amnion and decidua cells [44] , production of renin and prolactin by decidua cells [45, 46] , secretion of progesterone from bovine granulosa cells [47] , and activation of phospholipase A2 (PLA2) and phospholipase C (PLC) in endometrium [48] . Recently, we found that ET-1 and ET-3 increased the intracellular calcium ion concentration and inhibited hCG secretion by cultured human trophoblasts (Yano, J. & Sagawa, N., unpublished observation). Table 1 summarizes the reported ET-1 actions on the in- 
Effects of amniotic ET on decidual function
A relatively high concentration of ET-1 (approximately 1 pmol/g wet weight) are detected in the human amnion, chorion laeve, and decidua vera tissues at term [33] . As listed in Table 1 , ET-1 at this concentration substantially alters various cell functions in intrauterine tissues. Moreover, in membrane preparations of placenta, decidua vera, and chorion laeve, high affinity and high capacity binding sites for [125I]ET-1 and [125I]ET-3 are detected throughout gestation. Thus, both the ligand ET-1 and ET receptors are present in intrauterine tissues. Another point to be noted is that only a small amount of ET-1-LI can be detected in the culture medium of decidua cells and that prepro-ET-1 mRNA is not detected in this tissue by Northern blot analysis [7] , although a relatively large amount of ET-1-LI is detected in the homogenate of decidua vera tissue [33] . These findings suggest that ET-1 in decidua vera is derived, at least in part, from amnion cells. Therefore, it is plausible that some of the decidual functions such as renin secretion [45] and prolactin secretion [46] can be affected by ET-1 secreted from amnion cells.
Effects of amniotic ET on myometrial contraction
Myometrium also has abundant ET-AR, the activation of which induces myometrial contraction in vitro [34] . However, the pregnant uterus in vivo does not contract in a coordinated manner during normal pregnancy before term. One of the reasons for this phenomenon may be the limited availability of ET ligand in the myometrium during the second trimester. In amnion tissue during the second trimester, only ET-AR is detected, while ET-BR is not found. Moreover, in a membrane preparation of this tissue at term, neither ET-AR nor ET-BR is detected. Thus, ET-1 secreted from amnion cells may be trapped by the abundant ET-receptors in amnion, chorion and decidua cells during the second trimester and may not reach the myometrium. At term, secretion of ET-1 from amnion cells increases, but because the peptide can no longer be trapped in the amnion, it distributes through the chorion laeve and decidua vera and finally reaches the myometrium, which has an abundance of ET-AR.
Conclusion
It is still not clear whether amniotic ET plays a crucial role in the initiation of labor or whether the high concentration of ET in the lower amniotic cavity at term is due primarily to the onset of labor. As reviewed in this paper, however, both high concentrations of ET-1 and abundant ET-AR and ET-BR (except for ET-receptors in amnion tissue at term) are present in intrauterine tissues. Therefore, it is theoretically possible that ET-1 plays a physiological role in human pregnancy. The specific agonists as well as antagonists for ET-AR and ET-BR that were developed recently [50] [51] [52] [53] will help in elucidating the physiological functions of ET in these intrauterine tissues and provide indications as to the role of amniotic ET in pregnancy. 
